Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Clinical Studies

Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients

Persa, Oana D.*,†; Schatton, Kerstin†,‡; Rübben, Albert†,§; Berking, Carola∥,¶; Erdmann, Michael∥,¶; Schlaak, Max#,**; Mauch, Cornelia*,†; Steeb, Theresa∥,¶

Author Information
doi: 10.1097/CJI.0000000000000375
  • Buy

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.